, Volume 45, Issue 9, pp 618–625 | Cite as

Malignant peripheral nerve sheath tumours in neurofibromatosis type 1: MRI supports the diagnosis of malignant plexiform neurofibroma

  • V. F. Mautner
  • R. E. Friedrich
  • A. von Deimling
  • C. Hagel
  • B. Korf
  • M. T. Knöfel
  • R. Wenzel
  • C. Fünsterer
Diagnostic Neuroradiology


Plexiform neurofibroma (PNF) is a typical feature of neurofibromatosis 1 (NF1). About 10% of patients with NF1 develop malignant peripheral nerve-sheath tumours (MPNST), usually arising from PNF, and this is the major cause of poor survival. A better prognosis can be achieved if the tumours are diagnosed at an early stage. Our objective was to establish MRI criteria for MPNST and to test their usefulness in detecting early malignant change in PNF. MRI was performed on 50 patients with NF1 and nerve-sheath tumours, of whom seven had atypical pain, tumour growth or neurological deficits indicative of malignancy; the other 43 were asymptomatic. On MRI all seven symptomatic patients had inhomogeneous lesions, due to necrosis and haemorrhage and patchy contrast enhancement. In one patient, the multiplicity of confluent tumours with inhomogeneous areas in addition to central lesions did not allow exclusion of malignancy. Only three of the 43 asymptomatic patients had comparable changes; the other 40 patients had tumours being of relatively homogeneous structure on T1- and T2-weighted images before and after contrast enhancement. All three asymptomatic patients with inhomogeneous lesions were shown to have MPNST.


Neurofibromatosis type 1 Malignant peripheral nerve-sheath tumour Plexiform neurofibroma Magnetic resonance imaging 



This study was supported by Deutsche Krebshilfe Grant No. 70-2794-De 1 and the Hamburger Stiftung zur Förderung der Krebsbekämpfung No. 161.


  1. 1.
    Huson SM, Harper PS, Compston DAS (1988) Von Recklinghausen neurofibromatosis – a clinical and population study in South-East Wales. Brain 111: 1355–1381PubMedGoogle Scholar
  2. 2.
    Tonsgard JH, Kwak SM, Short P, Dachman AH (1988) CT imaging in adults with neurofibromatosis 1. Frequent asymptomatic plexiform lesions. Neurology 50: 1755–1760Google Scholar
  3. 3.
    McGaughran JM, Harris DI, Donnai D, et al (1999) A clinical study of type 1 neurofibromatosis in north west England. J Med Genet 36: 197–203PubMedGoogle Scholar
  4. 4.
    Rasmussen SA, Quanhe Y, Friedman JM (2001) Mortality in neurofibromatosis 1: an analysis using U.S. death certificates. Am J Hum Genet 68: 1110–1118Google Scholar
  5. 5.
    Ferner RE, Gutmann D (2002) International consensus statement on malignant peripheral nerve sheath tumors in neurofibromatosis 1. Cancer Res 62: 1573–777PubMedGoogle Scholar
  6. 6.
    Leroy K, Dumas V, Martin-García N, et al (2001) Malignant peripheral nerve sheath tumors associated with neurofibromatosis type 1. Arch Dermatol 137: 908–913PubMedGoogle Scholar
  7. 7.
    King AA, DeBaun MR, Riccardi VM, Gutmann DH (2000) Malignant peripheral nerve sheath tumors in neurofibromatosis 1. Am J Med Genet 93: 388–392CrossRefPubMedGoogle Scholar
  8. 8.
    Wong WW, Hirose T, Scheithauer BW, Schild SE, Gunderson LL (1998) Malignant peripheral nerve sheath tumor: analysis of treatment outcome. Int J Radiat Oncol Biol Phys 42: 351–360CrossRefPubMedGoogle Scholar
  9. 9.
    Kluwe L, Friedrich RE, Korf B, Fahsold R, Mautner VF (2002) NF1 mutations in neurofibromatosis 1 patients with plexiform neurofibromas. Hum Mut 19: 309CrossRefGoogle Scholar
  10. 10.
    Cerofolini E, Landi A, DeSantis G, Maiorana A, Canossi G, Romagnoli R (1991) MR of benign peripheral nerve sheath tumors. J Comput Assist Tomogr 15: 593–597PubMedGoogle Scholar
  11. 11.
    Bhargava R, Parham DM, Lasater OE, Chari RS, Chen G, Fletcher BD (1997) MR imaging differentiation of benign and malignant peripheral nerve sheath tumors: use of the target sign. Pediatr Radiol 27: 124–129CrossRefPubMedGoogle Scholar
  12. 12.
    Levine E, Huntrakoon M, Wetzel LH (1987) Malignant nerve-sheath neoplasms in neurofibromatosis: distinction from benign tumors by using imaging techniques. Am J Roentgenol 149: 1059–1064PubMedGoogle Scholar

Copyright information

© Springer-Verlag 2003

Authors and Affiliations

  • V. F. Mautner
    • 1
  • R. E. Friedrich
    • 2
  • A. von Deimling
    • 3
  • C. Hagel
    • 4
  • B. Korf
    • 5
  • M. T. Knöfel
    • 6
  • R. Wenzel
    • 7
  • C. Fünsterer
    • 7
  1. 1.Department of NeurologyKlinikum Nord HamburgHamburgGermany
  2. 2.Department of Maxillofacial SurgeryUniversitätsklinikum EppendorfHamburgGermany
  3. 3.Department of NeuropathologyCharitéBerlinGermany
  4. 4.Department of NeuropathologyUniversitätsklinikum EppendorfHamburgGermany
  5. 5.Partners Center for Human GeneticsHarvard Institutes of MedicineBostonUSA
  6. 6.Department of SurgeryUniversitätsklinikum EppendorfHamburgGermany
  7. 7.MRI-Institute Hamburg OthmarschenHamburgGermany

Personalised recommendations